Athersys

Activities: Pharmaceutical Cell & Gene Therapy

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Effective ways to optimise heat exchangers Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
  5. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Research & Development

Cell Therapy Catapult signs multiple collaboration agreements

With the aim of accelerating the development of regenerative medicine
Research & Development

Athersys and Chugai link up to develop MultiStem cell therapy for ischemic stroke in Japan

Athersys will receive an upfront cash payment of US$10m from Chugai
Research & Development

CT Catapult to work with US biopharmaceutical company Athersys

On projects to advance European development of MultiStem therapy
Subscribe now